Abuse of Indigenous Psilocybin Mushrooms: A New Fashion and Some Psychiatric Complications
Clive E. Hyde, Graham Glancy, P. Omerod, David E. Hall, Gary Taylor
The British Journal of Psychiatry June 1, 1978 DOI: 10.1192/bjp.132.6.602 via OpenAlex
Summary
AI-generated from the abstractThree patients who used the indigenous British mushroom Psilocybe semilanceata for hallucinogenic purposes experienced typical psychedelic effects, transient psychotic states, and more prolonged schizophrenia-like conditions. Two patients showed sympathomimetic signs, one of which was prolonged. The authors suggest that clinicians in medical or psychiatric emergency clinics should inquire about such mushroom abuse when evaluating patients.
Study at a glance
| Characteristics | Case series Case report Peer reviewed |
|---|---|
| Sample size | 3 |
| Population | Patients presenting to medical or psychiatric emergency clinics after using Psilocybe semilanceata |
| Intervention | Psilocybe semilanceata |
| Topics | Psilocybin |
| Keywords | Indigenous Hallucinogen Psychiatry Schizophrenia object-oriented programming |
| Citations | 47 |
| Key finding | Use of Psilocybe semilanceata can cause typical psychedelic effects, transient psychosis, and prolonged schizophrenia-like states, with sympathomimetic signs in some cases. |
Abstract
Summary The use for hallucinogenic purposes of an indigenous mushroom, Psilocybe semilanceata indigenous to Britain is reported in three patients. Typical psychedelic, transient psychotic and more prolonged schizophrenia-like states were seen, with sympathomimetic signs noted in two cases, in one being prolonged. Enquiry about such mushroom abuse should be considered in individuals presenting to medical or psychiatric emergency clinics.